A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer ( PALAVY )

Disease Sites:

Breast

Staging:

Phase II

Age Group:

Adults

Therapies:

Mol. targeted/Immunotherapy/Biologics, Therapy (NOS)

Drugs:

Avelumab, Hydroxychloroquine, Palbociclib

Principal Investigator(s):

Reid, Sonya

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

06-23-2022

Trial Type:

Treatment

Protocol ID:

VICCBRE2161

National Clinical Trial ID:

NCT04841148

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available